Coronavirus research suggests that the risk of protracted COVID is lower with the Omicron variant than with the Delta form.

Photo of author

By Creative Media News

According to the study from King’s College London, 4.4% of Omicron cases were long COVID, whereas 10.8% of Delta patients displayed evidence of long COVID.

New research reveals that the Omicron variation of coronavirus is less likely to produce protracted COVID than the Delta strain.

Depending on age and duration of immunization, the probabilities of developing extended COVID were between 20 and 50 percent lower in the Omicron variation compared to the Delta variant, according to a study done by King’s College London.

42 3
Coronavirus research suggests that the risk of protracted covid is lower with the omicron variant than with the delta form.

Researchers utilized data from the Zoe COVID Symptom study, and lead author Dr. Claire Steves stated, “The Omicron variant appears significantly less likely to cause long COVID than previous variants, but one out of every 23 individuals who contract COVID-19 continue to experience symptoms for more than four weeks.”

Given the number of people affected, we must continue to provide support at work, at home, and through the NHS.

Analysis revealed that 4.4% of Omicron cases had long COVID, whereas 10.8% of Delta cases displayed symptoms of long COVID.

During the Omicron period, however, the number of patients with lengthy COVID was larger due to the number of infections of the variation during its peak in the UK between December 2021 and February 2022.

According to the Office of National Statistics, the number of long-term COVID patients rose from 1,3 million in January 2022 to 2 million on May 1, 2022.

Long COVID is defined by the National Institute for Health and Care Excellence (Nice) as having new or persistent symptoms four weeks or more after the original infection.

Symptoms include weariness, shortness of breath, lack of focus, and joint discomfort, which can significantly limit daily activities for certain individuals.

The study, which was published in a letter to The Lancet, found 56,003 UK adults who tested positive between December 20, 2021, and March 9, 2022, when the Omicron allele was predominant.

Researchers compared these cases to 41,361 cases that tested positive for the first time between 1 June and 27 November 2021, when Delta was prevalent.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Skip to content